UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2870) 2870
Book Chapter (17) 17
Dissertation (17) 17
Publication (4) 4
Web Resource (4) 4
Magazine Article (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
meropenem (2608) 2608
science & technology (1786) 1786
life sciences & biomedicine (1639) 1639
humans (1222) 1222
microbiology (834) 834
infectious diseases (833) 833
antibiotics (781) 781
pharmacology & pharmacy (750) 750
microbial sensitivity tests (595) 595
anti-bacterial agents - pharmacology (550) 550
biological and medical sciences (545) 545
male (540) 540
imipenem (538) 538
medical sciences (519) 519
female (485) 485
drug resistance (476) 476
pharmacology. drug treatments (435) 435
thienamycins - pharmacology (427) 427
antibacterial agents (424) 424
bacteria (416) 416
antibiotics. antiinfectious agents. antiparasitic agents (369) 369
antimicrobial agents (354) 354
middle aged (346) 346
anti-bacterial agents - therapeutic use (338) 338
adult (326) 326
infections (324) 324
aged (315) 315
carbapenems (296) 296
thienamycins - therapeutic use (282) 282
hospitals (271) 271
patients (250) 250
biochemical phenomena, metabolism, and nutrition (249) 249
bacterial infections and mycoses (230) 230
pseudomonas aeruginosa (227) 227
carbapenems - pharmacology (222) 222
pathogens (219) 219
ceftazidime (217) 217
anti-bacterial agents - administration & dosage (216) 216
antibiotic resistance (216) 216
e coli (212) 212
polycyclic compounds (209) 209
thienamycins - administration & dosage (203) 203
ciprofloxacin (196) 196
treatment outcome (196) 196
pneumonia (193) 193
colistin (186) 186
pseudomonas aeruginosa - drug effects (186) 186
imipenem - pharmacology (183) 183
piperacillin (182) 182
analysis (179) 179
minimum inhibitory concentration (174) 174
vancomycin (171) 171
drug resistance in microorganisms (170) 170
antimicrobial resistance (169) 169
cefepime (169) 169
laboratories (169) 169
medicine (169) 169
mortality (169) 169
amikacin (165) 165
carbapenemase (165) 165
health aspects (165) 165
ertapenem (164) 164
animals (161) 161
thienamycins - pharmacokinetics (159) 159
pharmacokinetics (158) 158
tazobactam (158) 158
research article (152) 152
beta-lactamases - metabolism (150) 150
klebsiella (143) 143
beta-lactamases - genetics (141) 141
anti-bacterial agents - pharmacokinetics (138) 138
gram-negative bacteria (137) 137
immunology (133) 133
research (132) 132
beta lactam antibiotics (131) 131
drug resistance, bacterial (131) 131
adolescent (130) 130
internal medicine (128) 128
risk factors (128) 128
aged, 80 and over (127) 127
clinical isolates (127) 127
genes (126) 126
nosocomial infections (124) 124
pharmacology (124) 124
science & technology - other topics (123) 123
epidemiology (122) 122
multidisciplinary sciences (122) 122
ampicillin (120) 120
bacterial infections (120) 120
carbapenem (117) 117
gentamicin (117) 117
science (116) 116
infection (115) 115
multidrug resistance (114) 114
antiinfectives and antibacterials (113) 113
sepsis (113) 113
drug therapy, combination (112) 112
polymerase chain reaction (110) 110
child (109) 109
general & internal medicine (109) 109
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2764) 2764
Japanese (57) 57
Chinese (45) 45
Spanish (36) 36
Portuguese (27) 27
German (24) 24
French (11) 11
Turkish (11) 11
Italian (8) 8
Russian (7) 7
Slovak (7) 7
Polish (3) 3
Czech (2) 2
Belarusian (1) 1
Croatian (1) 1
Hungarian (1) 1
Indonesian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical therapeutics, ISSN 0149-2918, 04/2020, Volume 42, Issue 4, pp. 692 - 702
carbapenemase-producing organisms | Klebsiella pneumonia carbapenemase | meropenem-vaborbactam | vaborbactam | multidrug-resistant gram-negative organisms | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Heterocyclic Compounds, 1-Ring - pharmacokinetics | Humans | Boronic Acids - adverse effects | Meropenem - adverse effects | Boronic Acids - chemistry | Meropenem - administration & dosage | Heterocyclic Compounds, 1-Ring - administration & dosage | Drug Interactions | Heterocyclic Compounds, 1-Ring - chemistry | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - pharmacokinetics | Boronic Acids - pharmacokinetics | Heterocyclic Compounds, 1-Ring - adverse effects | Meropenem - pharmacokinetics | Anti-Bacterial Agents - adverse effects | Boronic Acids - administration & dosage | Meropenem - chemistry | Anti-Bacterial Agents - administration & dosage | Drug Combinations | Drug resistance in microorganisms | Pneumonia | Bacterial infections | Tazobactam | Bacterial pneumonia | Beta lactamases | Urinary tract infections | Permeability | Drug approval | Klebsiella | Enterobacter cloacae | Hemodialysis | Clinical trials | Carbapenemase | Organisms | Infections | Urinary tract | Drug resistance | Chloride | Bacterial diseases | E coli | Piperacillin | Bacteria | Pseudomonas aeruginosa | Meropenem | Drug dosages | Efflux | Enzymes | Pharmacodynamics | Drug interactions | Piperacillin-tazobactam | Pharmacology | FDA approval | Bacteremia | Chemotherapy | Acids | Antibiotics | Pyelonephritis | Minimum inhibitory concentration | Skin | Renal replacement therapy | Pharmacokinetics | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 729 - 740
Journal Article
Journal Article